drugset / Trial / NCT00677859
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia
Non-randomizedParallel-groupOpen-labelSupportive care
Summary
The purpose of this study is to determine if MultiStem® can safely be given to patients with acute leukemia, chronic myeloid leukemia, or myelodysplasia after they have received hematopoietic stem cell transplantation.
Timeline
- Start
- 2008-07
- Primary completion
- 2011-10
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MultiStem | Cell therapy | — | Intravenous |